About Gynesonics
Gynesonics is a private company based in Redwood City, California. It has reported $299,097,132 raised in 12 offerings on Form D since November 2009. Its chief executive is Louis Baldino.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 6, 2023 | Apr 21, 2023amended Nov 6, 2023 | $92,184,203fully sold | 13 | $7.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 15, 2021 | Dec 29, 2021 | $32,502,239of $50.0M target | 18 | $1.8M | Equity, Options, Includes the issuance of shares of Series B, C, D, E, F, and F-1 Prime Preferred Stock and Series C Prime Preferred Warrants in exchange for Series A,B,C,D,E,F and F-1 Preferred Stock and Series C Warrants held by certain stockholders and warrant holders.Rule 506(b) | Form D ↗ |
| Dec 18, 2018 | Jan 3, 2019 | $75,470,026of $76.9M target | 21 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Jul 14, 2015 | Jul 29, 2015 | $43,144,042of $46.7M target | 16 | $2.6M | EquityRule 506(b) | Form D ↗ |
| Apr 9, 2015 | Apr 22, 2015 | $3,000,000fully sold | 12 | $250K | Debt, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Feb 8, 2013 | Feb 21, 2013amended Jul 9, 2014 | $28,448,886of $35.4M target | 16 | $1.7M | Equity, DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 16, 2013 | Jan 24, 2013 | $900,180fully sold | 9 | $100K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Dec 5, 2012 | Dec 7, 2012 | $900,181fully sold | 9 | $100K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Feb 8, 2012 | Feb 22, 2012 | $5,001,000of $7.0M target | 8 | $625K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Oct 15, 2010 | Oct 29, 2010 | $455,000fully sold | 1 | $455K | Options, Securities on exercise06 | Form D ↗ |
| May 5, 2010 | May 10, 2010amended Jul 30, 2010 | $15,591,000of $20.6M target | 7 | $2.2M | Equity06 | Form D/A ↗1 earlier filing |
| Nov 4, 2009 | Nov 17, 2009 | $1,500,375of $3.0M target | 7 | $214K | Debt, Options, Securities on exercise06 | Form D ↗ |
| Total, 12 offerings | $299,097,132 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gynesonics's Form D filed Nov 6, 2023.
Earlier filings also listed Susan Stimson (director, last listed Dec 2021), Robert O'Holla (director, last listed Dec 2021), Mike Carusi (director, last listed Dec 2021), Karen Talmadge (director, last listed Dec 2021), Jordan Bajor (executive officer, last listed Dec 2021), Jeffrey Schwartz (director, last listed Dec 2021), David Neustaedter (director, last listed Dec 2021) and Christopher Owens (executive officer and director, last listed Dec 2021).